European Network for Gynaecological Oncological Trial Groups Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT03740165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

European Network for Gynaecological Oncological Trial Groups

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 3)

Endometrial Neoplasms (Phase 3)

Fallopian Tube Neoplasms (Phase 3)

Ovarian Neoplasms (Phase 3)

Peritoneal Neoplasms (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7